C50.029 coverage policies: Medicare and commercial

C50.029 coverage policies: Medicare and commercial payers

121 active Medicare policies list C50.029, and 2 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for C50.029

Free account. Policy pages stay open to everyone.

Medicare policies listing C50.029

Showing 100 of 121

LCD · FIRST_COAST-L36499

BRCA1 and BRCA2 Genetic Testing

J9 · Effective Apr 11, 2016

LCD · NGS-J6-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

J6 · Effective Oct 1, 2015

LCD · NGS-JK-L33394

Drugs and Biologicals, Coverage of, for Label and Off-Label Uses

JK · Effective Oct 1, 2015

LCD · NGS-J6-L37810

Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

J6 · Effective Apr 1, 2019

LCD · NGS-JK-L37810

Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms

JK · Effective Apr 1, 2019

LCD · NORIDIAN-JE-L34215

Lab: Flow Cytometry

JE · Effective Oct 1, 2015

LCD · NORIDIAN-JF-L34215

Lab: Flow Cytometry

JF · Effective Oct 1, 2015

LCD · PALMETTO-JJ-L34513

Lab: Flow Cytometry

JJ · Effective Oct 1, 2015

LCD · PALMETTO-JM-L34513

Lab: Flow Cytometry

JM · Effective Oct 1, 2015

LCD · PALMETTO-JJ-L39387

Commercial payer policies listing C50.029

2 policies from 2 payers

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Aetna

Aetna policies listing C50.029, with the code’s status in each
Policy	Effective	Status of C50.029
Tumor MarkersPayerPolicy · AETNA-CPB-0352	Mar 5, 2024	Covered

Anthem

Anthem policies listing C50.029, with the code’s status in each
Policy	Effective	Status of C50.029
Mastectomy for GynecomastiaClinical Guideline · ANTHEM-CG-SURG-88	Apr 15, 2026	Covered